Who Paid My Doc
Thomas McGovern
MOHS-Micrographic Surgery Fort Wayne, IN Medical Doctor
NPI 1982702742 CMS profile 225855
7881 Carnegie Blvd, Fort Wayne, IN 46804
General payments
$3,870
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Thomas McGovern of Fort Wayne, IN is reported in the CMS Open Payments database as having received $3,870 across 45 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 69th percentile of MOHS-Micrographic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $681 | 13 | |
| 2024 | General | $1,003 | 12 | |
| 2023 | General | $2,077 | 13 | |
| 2022 | General | $15 | 1 | |
| 2021 | General | $48 | 3 | |
| 2020 | General | $26 | 2 | |
| 2019 | General | $19 | 1 |
Beside peers
- Thomas McGovern
- MOHS-Micrographic Surgery median
- Middle half of MOHS-Micrographic Surgery
- National median
In program year 2025, general payments to Thomas McGovern were reported at $681. Among 1,077 MOHS-Micrographic Surgery profiles paid that year, the median was $465 and the middle half received between $145 and $1,066.
Show as a table
| Year | Thomas McGovern | MOHS-Micrographic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $19 | $316 | $106–$785 | $163 |
| 2020 | $26 | $162 | $68–$412 | $114 |
| 2021 | $48 | $243 | $87–$654 | $132 |
| 2022 | $15 | $300 | $102–$887 | $149 |
| 2023 | $2,077 | $364 | $125–$1,010 | $160 |
| 2024 | $1,003 | $445 | $142–$1,108 | $164 |
| 2025 | $681 | $465 | $145–$1,066 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
1,391
Drug cost
$15,041
Branded share of claims
7.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Mupirocin | Generic | 983 | $6,561 | |
| Santyl Collagenase Clostridium Hist. | Brand | 20 | $5,952 | |
| Silver Sulfadiazine | Generic | 96 | $514 | |
| Gentamicin Sulfate | Generic | 14 | $447 | |
| Doxycycline Hyclate | Generic | 54 | $442 | |
| Minocycline Hcl | Generic | 51 | $303 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 56 | $240 | |
| Ssd Silver Sulfadiazine | Brand | 32 | $179 | |
| Clindamycin Hcl | Generic | 18 | $151 | |
| Triamcinolone Acetonide | Generic | 48 | $149 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 138 Part D prescribers listed as Undefined Physician type; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 48 billing codesPaid by Medicare
$618,006
Medicare patients
604
Services billed
2,095
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 42% | |
| Ischemic heart disease | 32% | |
| Chronic kidney disease | 30% | |
| Diabetes | 29% | |
| Atrial fibrillation | 22% | |
| Depression | 19% | |
| Heart failure | 13% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
45 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other MOHS-Micrographic Surgery in Indiana
Carl Hanke
MOHS-Micrographic Surgery · Indianapolis, IN
Rachel Ward
MOHS-Micrographic Surgery · Muncie, IN
Eduardo Rivera
MOHS-Micrographic Surgery · Madison, IN
John Randall
MOHS-Micrographic Surgery · West Lafayette, IN
David Surprenant
MOHS-Micrographic Surgery · Evansville, IN
Brian Williams
MOHS-Micrographic Surgery · Greenwood, IN
Related records
MOHS-Micrographic Surgery in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All MOHS-Micrographic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.